Literature DB >> 22249920

A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment.

Shou-Hsia Cheng1, Tai-Ti Lee, Chi-Chen Chen.   

Abstract

BACKGROUND: Numerous studies have examined the impacts of pay-for-performance programs, yet little is known about their long-term effects on health care expenses.
OBJECTIVES: This study aimed to examine the long-term effects of a pay-for-performance program for diabetes care on health care utilization and expenses.
METHODS: This study represents a nationwide population-based natural experiment with a 4-year follow-up period under a compulsory universal health insurance program in Taiwan. The intervention groups consisted of 20,934 patients enrolled in the program in 2005, and 9694 patients continuously participated in the program for 4 years. Two comparison groups were selected by propensity score matching from patients seen by the same group of physicians. Generalized estimating equations were used to estimate differences-in-differences models to examine the effects of the pay-for-performance program.
RESULTS: Patients enrolled in the pay-for-performance program underwent significantly more diabetes specific examinations and tests after enrollment; the differences between the intervention and comparison groups declined gradually over time but remained significant. Patients in the intervention groups had a significantly higher number of diabetes-related physician visits in only the first year after enrollment and had fewer diabetes-related hospitalizations in the follow-up period. Concerning overall health care expenses, patients in the intervention groups spent more than the comparison group in the first year; however, the continual enrollees spent significantly less than their counterparts in the subsequent years.
CONCLUSIONS: The program seemed to achieve its primary goal in improving health care and providing long-term cost benefits.

Entities:  

Mesh:

Year:  2012        PMID: 22249920     DOI: 10.1097/MLR.0b013e31822d5d36

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  31 in total

1.  Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.

Authors:  Hui-Min Hsieh; Shu-Ling Tsai; Lih-Wen Mau; Herng-Chia Chiu
Journal:  Health Serv Res       Date:  2015-07-07       Impact factor: 3.402

2.  Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data.

Authors:  Jonathan Sicsic; Carine Franc
Journal:  Eur J Health Econ       Date:  2016-06-21

3.  Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems.

Authors:  Karen Eggleston; Brian K Chen; Chih-Hung Chen; Ying Isabel Chen; Talitha Feenstra; Toshiaki Iizuka; Janet Tin Kei Lam; Gabriel M Leung; Jui-Fen Rachel Lu; Beatriz Rodriguez-Sanchez; Jeroen N Struijs; Jianchao Quan; Joseph P Newhouse
Journal:  Eur J Health Econ       Date:  2020-02-20

4.  Access to chiropractic care and the cost of spine conditions among older adults.

Authors:  Matthew A Davis; Olga Yakusheva; Haiyin Liu; Joshua Tootoo; Marita G Titler; Julie P W Bynum
Journal:  Am J Manag Care       Date:  2019-08-01       Impact factor: 2.229

5.  Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.

Authors:  Jui-Fen Rachel Lu; Ying Isabel Chen; Karen Eggleston; Chih-Hung Chen; Brian Chen
Journal:  Eur J Health Econ       Date:  2022-08-22

6.  Patients' views on pay for performance in France: a qualitative study in primary care.

Authors:  Olivier Saint-Lary; Claire Leroux; Cécile Dubourdieu; Cécile Fournier; Irène François-Purssell
Journal:  Br J Gen Pract       Date:  2015-08       Impact factor: 5.386

7.  Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

Authors:  Elise Chia-Hui Tan; Raoh-Fang Pwu; Duan-Rung Chen; Ming-Chin Yang
Journal:  Qual Life Res       Date:  2013-08-23       Impact factor: 4.147

Review 8.  The evolution of Taiwan's National Health Insurance drug reimbursement scheme.

Authors:  Jason C Hsu; Christine Y Lu
Journal:  Daru       Date:  2015-02-10       Impact factor: 3.117

9.  Socioeconomic disparities in preventable hospitalization among adults with diabetes in Taiwan: a multilevel modelling approach.

Authors:  Pei-Ching Chen; Ching-Yao Tsai; Lin-Chung Woung; Yue-Chune Lee
Journal:  Int J Equity Health       Date:  2015-03-21

10.  Pay-for-performance: impact on diabetes.

Authors:  Tim Doran; Evangelos Kontopantelis
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.